Financhill
Buy
52

PYPL Quote, Financials, Valuation and Earnings

Last price:
$58.03
Seasonality move :
-1.19%
Day range:
$58.34 - $59.04
52-week range:
$55.85 - $93.25
Dividend yield:
0.24%
P/E ratio:
11.71x
P/S ratio:
1.75x
P/B ratio:
2.70x
Volume:
13M
Avg. volume:
15.6M
1-year change:
-31.6%
Market cap:
$54.6B
Revenue:
$31.8B
EPS (TTM):
$4.98
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $21.4B $25.6B $27.1B $29.7B $31.8B
Revenue Growth (YoY) 22.24% 19.26% 5.85% 9.7% 7.1%
 
Cost of Revenues $9.6B $13.5B $14.3B $16.3B $17.5B
Gross Profit $11.8B $12.1B $12.8B $13.4B $14.3B
Gross Profit Margin 55.08% 47.38% 47.3% 45.23% 45.09%
 
R&D Expenses $2.6B $3B $3.3B $3B $3B
Selling, General & Admin $3.9B $4.6B $4.4B $3.9B $4.1B
Other Inc / (Exp) $1.8B -$50M -$548M $334M -$714M
Operating Expenses $8.4B $7.6B $9.2B $8.6B $8.6B
Operating Income $3.4B $4.5B $3.6B $4.9B $5.8B
 
Net Interest Expenses $209M $232M $304M $347M $382M
EBT. Incl. Unusual Items $5.1B $4.1B $3.4B $5.4B $5.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $863M -$70M $947M $1.2B $1.2B
Net Income to Company $4.2B $4.2B $2.4B $4.2B $4.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.2B $4.2B $2.4B $4.2B $4.1B
 
Basic EPS (Cont. Ops) $3.58 $3.55 $2.10 $3.85 $4.03
Diluted EPS (Cont. Ops) $3.54 $3.52 $2.09 $3.84 $3.99
Weighted Average Basic Share $1.2B $1.2B $1.2B $1.1B $1B
Weighted Average Diluted Share $1.2B $1.2B $1.2B $1.1B $1B
 
EBITDA $4.6B $5.8B $4.9B $5.9B $6.8B
EBIT $3.4B $4.5B $3.6B $4.9B $5.8B
 
Revenue (Reported) $21.4B $25.6B $27.1B $29.7B $31.8B
Operating Income (Reported) $3.4B $4.5B $3.6B $4.9B $5.8B
Operating Income (Adjusted) $3.4B $4.5B $3.6B $4.9B $5.8B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $6.2B $6.7B $7.4B $7.9B $8.5B
Revenue Growth (YoY) 13.7% 7.45% 10.78% 6.05% 7.74%
 
Cost of Revenues $3.3B $3.9B $4.5B $4.6B $5B
Gross Profit $2.9B $2.8B $2.9B $3.2B $3.5B
Gross Profit Margin 46.42% 42.24% 38.97% 41.21% 41.03%
 
R&D Expenses $755M $801M $739M $746M $801M
Selling, General & Admin $1B $1B $949M $1B $1B
Other Inc / (Exp) $164M $443M -$4M -$220M --
Operating Expenses $1.8B $1.8B $1.7B $1.8B $1.8B
Operating Income $1.1B $1B $1.2B $1.5B $1.6B
 
Net Interest Expenses $58M $87M $86M $106M $113M
EBT. Incl. Unusual Items $1.2B $1.6B $1.2B $1.3B $1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $78M $248M $221M $301M $285M
Net Income to Company $1.1B $1.3B $1B $1B $1.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.1B $1.3B $1B $1B $1.2B
 
Basic EPS (Cont. Ops) $0.93 $1.15 $0.93 $1.00 $1.31
Diluted EPS (Cont. Ops) $0.92 $1.15 $0.93 $0.99 $1.30
Weighted Average Basic Share $1.2B $1.2B $1.1B $1B $950M
Weighted Average Diluted Share $1.2B $1.2B $1.1B $1B $960M
 
EBITDA $1.4B $1.3B $1.5B $1.7B $1.9B
EBIT $1.1B $1B $1.2B $1.5B $1.6B
 
Revenue (Reported) $6.2B $6.7B $7.4B $7.9B $8.5B
Operating Income (Reported) $1.1B $1B $1.2B $1.5B $1.6B
Operating Income (Adjusted) $1.1B $1B $1.2B $1.5B $1.6B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $24.8B $26.7B $28.9B $31.5B $32.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.8B $15.4B $17.4B $18.8B $19.2B
Gross Profit $12B $11.3B $11.5B $12.6B $13.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3B $3.2B $3B $3B $3.1B
Selling, General & Admin $4.5B $4.6B $3.9B $3.9B $4.3B
Other Inc / (Exp) $1.1B -$695M -$151M -$251M --
Operating Expenses $7.5B $7.8B $6.9B $6.9B $7.4B
Operating Income $4.5B $3.5B $4.6B $5.7B $6.3B
 
Net Interest Expenses $232M $274M $349M $372M $427M
EBT. Incl. Unusual Items $5.3B $3B $4.7B $5.7B $6.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $317M $663M $963M $1.3B $1.2B
Net Income to Company $4.9B $2.3B $3.8B $4.4B $4.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.9B $2.3B $3.8B $4.4B $4.9B
 
Basic EPS (Cont. Ops) $4.21 $1.98 $3.37 $4.21 $5.04
Diluted EPS (Cont. Ops) $4.15 $1.97 $3.36 $4.19 $4.98
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $5.7B $4.8B $5.7B $6.8B $7.3B
EBIT $4.5B $3.5B $4.6B $5.7B $6.3B
 
Revenue (Reported) $24.8B $26.7B $28.9B $31.5B $32.9B
Operating Income (Reported) $4.5B $3.5B $4.6B $5.7B $6.3B
Operating Income (Adjusted) $4.5B $3.5B $4.6B $5.7B $6.3B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $18.6B $19.8B $21.7B $23.5B $24.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $9.6B $11.6B $13.2B $14B $14.3B
Gross Profit $9B $8.2B $8.5B $9.4B $10.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.2B $2.4B $2.2B $2.2B $2.3B
Selling, General & Admin $3.3B $3.3B $2.8B $2.9B $3.1B
Other Inc / (Exp) $251M -$394M $3M -$582M -$147M
Operating Expenses $5.6B $5.7B $5.1B $5.1B $5.4B
Operating Income $3.5B $2.5B $3.4B $4.3B $4.9B
 
Net Interest Expenses $173M $215M $260M $285M $330M
EBT. Incl. Unusual Items $3.4B $2.3B $3.6B $3.9B $4.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $25M $758M $774M $893M $869M
Net Income to Company $3.4B $1.5B $2.8B $3B $3.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.4B $1.5B $2.8B $3B $3.8B
 
Basic EPS (Cont. Ops) $2.87 $1.30 $2.56 $2.91 $3.92
Diluted EPS (Cont. Ops) $2.84 $1.29 $2.55 $2.89 $3.88
Weighted Average Basic Share $3.5B $3.5B $3.3B $3.1B $2.9B
Weighted Average Diluted Share $3.6B $3.5B $3.3B $3.1B $2.9B
 
EBITDA $4.4B $3.5B $4.2B $5.1B $5.6B
EBIT $3.5B $2.5B $3.4B $4.3B $4.9B
 
Revenue (Reported) $18.6B $19.8B $21.7B $23.5B $24.6B
Operating Income (Reported) $3.5B $2.5B $3.4B $4.3B $4.9B
Operating Income (Adjusted) $3.5B $2.5B $3.4B $4.3B $4.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $13.1B $9.5B $10.9B $14.1B $10.8B
Short Term Investments $8.3B $4.2B $3.1B $5B $4.3B
Accounts Receivable, Net $34B $36.9B $37.2B $40B $38.7B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.1B $1.3B $1.9B $2.5B $4.7B
Total Current Assets $51B $52.6B $57.4B $62.6B $61.1B
 
Property Plant And Equipment $2.5B $2.6B $2.3B $1.9B $2.1B
Long-Term Investments $6.1B $6.8B $5B $3.4B $4.8B
Goodwill $9.1B $11.5B $11.2B $11B $10.8B
Other Intangibles $1B $1.3B $788M $537M $326M
Other Long-Term Assets $1.3B $1.7B $2.5B $3.3B $3.3B
Total Assets $70.4B $75.8B $78.6B $82.2B $81.6B
 
Accounts Payable $35.7B $39B $40.1B $42.1B $39.9B
Accrued Expenses $2.6B $3.8B $4.9B $6.4B $8.5B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $38.4B $43B $45B $48.5B $48.4B
 
Long-Term Debt $9.6B $8.7B $11B $10.1B $10.5B
Capital Leases -- -- -- -- --
Total Liabilities $50.3B $54.1B $58.4B $61.1B $61.2B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$484M -$136M -$928M -$746M -$550M
Common Equity $20B $21.7B $20.3B $21.1B $20.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $44M -- -- -- --
Total Equity $20.1B $21.7B $20.3B $21.1B $20.4B
 
Total Liabilities and Equity $70.4B $75.8B $78.6B $82.2B $81.6B
Cash and Short Terms $13.1B $9.5B $10.9B $14.1B $10.8B
Total Debt $9.6B $9.7B $11.4B $11.3B $11.7B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $13.3B $10.8B $11.5B $11.9B $10.8B
Short Term Investments $5.5B $4.2B $4.7B $4.6B --
Accounts Receivable, Net $35.8B $35.7B $35.6B $40.2B $39.6B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.3B $2.5B $2.2B $4.1B --
Total Current Assets $54.1B $55.1B $56.6B $62.7B $60.2B
 
Property Plant And Equipment $2.5B $2.4B $2B $2.1B $2.2B
Long-Term Investments $6.8B $6.2B $4.2B $4.4B $3.8B
Goodwill $9.6B $11.1B $10.9B $11B --
Other Intangibles $808M $855M $564M $393M --
Other Long-Term Assets $1.4B $2.4B $2.9B $3.7B --
Total Assets $74.5B $76.4B $76.4B $83.5B $79.8B
 
Accounts Payable $38B $37.9B $38.8B $41.3B $40.9B
Accrued Expenses $3.6B $4.2B $3.5B $8.9B --
Current Portion Of Long-Term Debt -- $418M -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $41.7B $43.2B $43.4B $50.3B $44.9B
 
Long-Term Debt $8.6B $10.8B $11.1B $10.7B $11.9B
Capital Leases -- -- -- -- --
Total Liabilities $52.4B $56.2B $56.7B $63.3B $59.6B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$124M -$681M -$852M -$627M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $22.1B $20.3B $19.7B $20.2B $20.2B
 
Total Liabilities and Equity $74.5B $76.4B $76.4B $83.5B $79.8B
Cash and Short Terms $13.3B $10.8B $11.5B $11.9B $10.8B
Total Debt $8.6B $10.8B $11.1B $13.1B $12B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $4.2B $4.2B $2.4B $4.2B $4.1B
Depreciation & Amoritzation $1.2B $1.3B $1.3B $1.1B $1B
Stock-Based Compensation $1.4B $1.4B $1.3B $1.5B $1.2B
Change in Accounts Receivable -$1.2B -$1.4B -$1.4B -$1.3B -$1B
Change in Inventories -- -- -- -- --
Cash From Operations $5.9B $6.3B $5.8B $4.8B $7.5B
 
Capital Expenditures $866M $908M $706M $623M $683M
Cash Acquisitions $3.6B $2.8B -- -- --
Cash From Investing -$16.2B -$5.5B -$3.3B $752M $1.6B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $7B $272M $3.5B $1.5B $2.2B
Long-Term Debt Repaid -$3B -$361M -$1.7B -$1.1B -$2.3B
Repurchase of Common Stock $1.6B $3.4B $4.2B $5B $6B
Other Financing Activities $10B $2.7B $1.1B $1.4B -$2.2B
Cash From Financing $12.5B -$764M -$1.2B -$3B -$8.3B
 
Beginning Cash (CF) $4.9B $5.3B $7.8B $9.1B $6.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.3B -$11M $1.1B $2.7B $556M
Ending Cash (CF) $7.3B $5.2B $8.8B $11.8B $6.9B
 
Levered Free Cash Flow $5B $5.4B $5.1B $4.2B $6.8B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $1.1B $1.3B $1B $1B $1.2B
Depreciation & Amoritzation $323M $330M $270M $255M $245M
Stock-Based Compensation $300M $226M $379M $284M $257M
Change in Accounts Receivable -$43M -$22M -$71M -$51M $126M
Change in Inventories -- -- -- -- --
Cash From Operations $1.5B $1.9B $1.3B $1.6B $2B
 
Capital Expenditures $227M $182M $158M $169M $256M
Cash Acquisitions -- -- -- -- --
Cash From Investing $326M $1.4B -$307M $2.8B $4.8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $58M $109M $598M --
Long-Term Debt Repaid -- -- -- -$466M --
Repurchase of Common Stock $350M $939M $1.4B $1.8B $1.5B
Other Financing Activities -$467M -$2.1B $1.4B -$885M --
Cash From Financing -$816M -$3.2B $61M -$2.5B -$1.8B
 
Beginning Cash (CF) $7.8B $6.7B $6.8B $7.3B $9B
Foreign Exchange Rate Adjustment -$72M -$117M -$45M $192M -$44M
Additions / Reductions $951M $40M $968M $2.1B $4.9B
Ending Cash (CF) $8.7B $6.6B $7.7B $9.5B $13.8B
 
Levered Free Cash Flow $1.3B $1.8B $1.1B $1.4B $1.7B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $4.9B $2.3B $3.8B $4.4B $4.9B
Depreciation & Amoritzation $1.2B $1.3B $1.1B $1B $978M
Stock-Based Compensation $1.4B $1.3B $1.4B $1.3B $1.1B
Change in Accounts Receivable -$1.4B -$1.3B -$1.3B -$1.2B -$1.1B
Change in Inventories -- -- -- -- --
Cash From Operations $5.8B $6.4B $3.4B $7.7B $6.4B
 
Capital Expenditures $921M $761M $636M $625M $861M
Cash Acquisitions $469M $2.3B -- -- --
Cash From Investing -$5.3B -$6.4B $1.2B -$1.4B $3.6B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $3.6B $958M $2.9B --
Long-Term Debt Repaid -- -$2B -$942M -$1.2B --
Repurchase of Common Stock $2.1B $4.7B $5.4B $5.4B $5.8B
Other Financing Activities $4.1B $604M $39M $1.9B --
Cash From Financing $2.3B -$3B -$4.8B -$1.7B -$7.6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.8B -$3.2B -$141M $4.9B $2.3B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $4.9B $5.7B $2.8B $7B $5.6B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $3.4B $1.5B $2.8B $3B $3.8B
Depreciation & Amoritzation $939M $991M $809M $783M $729M
Stock-Based Compensation $1.1B $967M $1.1B $947M $792M
Change in Accounts Receivable -$155M -$89M -$35M $31M $11M
Change in Inventories -- -- -- -- --
Cash From Operations $4.6B $4.7B $2.2B $5.1B $4B
 
Capital Expenditures $695M $548M $478M $480M $658M
Cash Acquisitions $469M -- -- -- --
Cash From Investing -$2.4B -$3.3B $1.3B -$868M $1.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $3.3B $829M $2.2B $1.9B
Long-Term Debt Repaid -- -$1.7B -$942M -$1.1B -$1.6B
Repurchase of Common Stock $1.9B $3.2B $4.4B $4.8B $4.6B
Other Financing Activities $1.6B -$542M -$1.6B -$1.1B $513M
Cash From Financing -$186M -$2.4B -$6B -$4.7B -$4B
 
Beginning Cash (CF) $19.3B $16.2B $19.5B $24.7B $23.2B
Foreign Exchange Rate Adjustment -$106M -$253M -$95M $103M $245M
Additions / Reductions $1.9B -$1.3B -$2.6B -$400M $1.4B
Ending Cash (CF) $21.1B $14.6B $16.8B $24.4B $24.8B
 
Levered Free Cash Flow $3.9B $4.1B $1.8B $4.6B $3.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.78% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock